A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast ...

A slow drug-release system has proven highly effective in treating certain bladder cancer patients whose tumors were previously unresponsive to therapy. A new targeted drug delivery system known as TA ...

From chemotherapy to immunotherapy, medical science has rewritten the story of survival and hope for blood cancer patients in ...

Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective Tregcells. These cells help ensure that the ...

Pancreatic cancer, also known as pancreatic ductal adenocarcinoma, is one of the most aggressive types of cancer. Despite ...

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive ...

HR-positive/HER2-negative breast cancer grows with estrogen or progesterone, lacking high HER2 protein levels, making hormone ...

The MarketWatch News Department was not involved in the creation of this content. This press release is not intended for UK media. -- HERNEXEOS(R) (zongertinib tablets) approved based on an objective ...

CD40-targeted therapies present major opportunities in immunotherapy for autoimmune diseases and cancers. The market is emerging with over 35 therapies in trials and is driven by technological ...

Ongoing investigation into whether bee venom could help treat a certain type of cancer has been making "important progress," the leading researcher has told Newsweek. Experts at the Epigenetics Lab at ...